This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
A third look at the use of Veklury and Paxlovid in Pediatric Covid patients
Ticker(s): PFE, GILDWho's the expert?
Institution: Preferred Pediatrics of Lafayette
- Primary care pediatrician
- sees approximately 10 cases a month currently for pediatric patients with SARS-CoV-2.
- familiar with Veklury and Paxlovid, but have not prescribed them.
Interview GoalDiscussing the use of Veklury(remdesivir) and Paxlovid in pediatric patients as well as the ongoing Phase 2/3 clinical trial study of Paxlovid for children under the age of 12.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
